Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis.
Min LiangNing LuoMafeng ChenChunna ChenShivank SinghShantanu SinghShifan TanPublished in: Infectious diseases and therapy (2021)
The estimated prevalence and mortality rate of COVID-19 in PLWHA were 0.774% and 8.814%, respectively. Since most of the included studies used unmatched populations, comparisons between PLWHA and non-PLWHA should be interpreted with caution. Further investigations are needed for a more comprehensive understanding of the relationship between cluster of differentiation 4 cell count, HIV viral load, antiretroviral therapy, and COVID-19 related prognosis in PLWHA.
Keyphrases
- antiretroviral therapy
- coronavirus disease
- hiv infected
- sars cov
- hiv positive
- human immunodeficiency virus
- risk factors
- hiv aids
- hiv infected patients
- hiv testing
- hepatitis c virus
- cardiovascular events
- men who have sex with men
- respiratory syndrome coronavirus
- south africa
- single cell
- cell therapy
- stem cells
- cardiovascular disease
- coronary artery disease